Tag: Life Sciences

Buffalo, N.Y. – Phillips Lytle LLP Partners Douglas W. Dimitroff and Lisa L. Smith have been selected for 2021 Law360 Editorial Advisory Boards. Mr. Dimitroff has been named to the Telecommunications Editorial Advisory Board, and Ms. Smith has been selected to the Life Sciences Editorial Advisory Board. The purpose of the editorial advisory boards is to provide insight to Law360 on trends in legal developments. Hundreds of lawyers contribute thought. Read More>>

Intensity’s team continues its growth trajectory in 2021 with the addition of Dr. Richard Manning. Dr. Manning brings over 25 years of expertise in biopharmaceutical and life science industries to the firm. San Diego, CA - Intensity, LLC, an economic consulting firm generating influential research and in-depth analysis, announced today the key hire of Managing Director Dr. Richard Manning, based in Washington, D.C. Dr. Manning will work closely with key. Read More>>

Michigan-based company recognized for the economic and social impact resulting from promoting innovation and helping entrepreneurs through SBIR/STTR funding. CHELSEA, Mich. –– BBCetc announced today that it is one of the recipients of the Tibbetts Awards given by the U.S. Small Business Administration (SBA). BBCetc is a women-owned business created in 1990 to help entrepreneurs secure and manage non-dilutive funding from government agencies and create a successful, sustainable company to deliver. Read More>>

New partners complement prestigious firm’s growing practice  RYE, N.Y. (Jan. 5, 2021) – Dorf & Nelson LLP, a private practice law firm headquartered in Rye, N.Y., is pleased to announce that former Westchester County District Attorney Anthony A. Scarpino, Jr. and former First Deputy District Attorney Paul J. Noto have joined the firm as partners, effective Jan. 5, 2021. “We are delighted to welcome Tony and Paul,” said Jon A. Dorf,. Read More>>

SpectronRx has announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for the HymonTMSARS-CoV-2 Test Kit, featuring specific clinical benefits: 1). 1.5-hour testing time, from prep to finish; 2). 94 sample capacity (+ controls) per kit; 3). LOD (Limit of Detection) of 1.2 copies of SARS-CoV-2 RNA/uL = 5 copies per reaction; 4). Low laboratory footprint requirement. The HymonTMSARS-CoV-2 Test Kit is a real-time RT-PCR. Read More>>

One of the key factors fuelling the rise in the demand for the blockchain technology in healthcare is the increasing implementation of stringent regulations by various governments across the world for safeguarding and protecting consumer information against data breach and theft. For instance, the European Union (EU) launched a data protection rule, known as the General Data Protection Regulation (GDPR), in May 2018, which aims to protect EU citizens from. Read More>>